Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group - Lusher, JM; Arkin, S; Abildgaard, CF (N Engl J Med, 1993)